Decoy Therapeutics Inc. - DCOY
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q2 2025
· Q1 2025
Value (USD)
Total reported value ($000)
$86K
QoQ value delta ($000)
+$51K
(+145.71%)
Implied price effect (QoQ)
+20.26%
Shares
Total shares
99,764
QoQ shares delta
+50,937
(+104.32%)
Total shares held by funds (by quarter)
Market chart (DCOY)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q2 2025)
Top 25 only
Full list
Early Q1 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| HRT FINANCIAL LP | 28 | 31,676 | 0.0% |
| UBS Group AG | 16 | 18,138 | 0.0% |
| GOLDMAN SACHS GROUP INC | 14 | 16,667 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 13 | 15,560 | 0.0% |
| BARCLAYS PLC | 7 | 8,024 | 0.0% |
| CITIGROUP INC | 5 | 5,889 | 0.0% |
| Tower Research Capital LLC (TRC) | 3 | 3,663 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 18 | 0.0% |
| MORGAN STANLEY | 0 | 7 | 0.0% |
| OSAIC HOLDINGS, INC. | 0 | 59 | 0.0% |
| ELEVATION POINT WEALTH PARTNERS, LLC | 0 | 61 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 1 | 0.0% |
| BlackRock, Inc. | 0 | 1 | 0.0% |